|
Schlusskurs
Shenzhen S.E.
22.01.2026
|
% 5 Tage
|
Veränd. 1. Jan.
|
|
57,21 CNY
|
+0,37 %
|
 |
-3,07 %
|
+0,12 %
|
|
21.12. |
Certain A Shares of Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd. are subject to a Lock-Up Agreement Ending on 21-DEC-2025.
| | |
24.10.25 |
Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2025
| | |
26.08.25 |
Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2025
| | |
22.04.25 |
Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2025
| | |
22.04.25 |
Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2024
| | |
10.02.25 |
Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd. Approves Board Elections
| | |
21.12.24 |
Certain A Shares of Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd. are subject to a Lock-Up Agreement Ending on 21-DEC-2024.
| | |
28.10.24 |
Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2024
| | |
14.08.24 |
Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2024
| | |
27.05.24 |
Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd. Announces Cash Dividend for the Year 2023, Payable on 3 June 2024
| | |
22.04.24 |
Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024
| | |
21.12.23 |
Tranche Update on Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd.'s Equity Buyback Plan announced on August 24, 2023.
| | |
20.12.23 |
Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd.'s Equity Buyback announced on August 24, 2023, has closed with 777,300 shares, representing 0.72% for CNY 49.99 million,
| | |
25.10.23 |
Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023
| | |
10.10.23 |
Tranche Update on Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd.'s Equity Buyback Plan announced on August 24, 2023.
| | |
18.09.23 |
Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd.(XSEC:301096) added to S&P Global BMI Index
| | |
24.08.23 |
Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd. announces an Equity Buyback for CNY 50 million worth of its shares.
| | |
24.08.23 |
Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd. authorizes a Buyback Plan.
| | |
09.08.23 |
Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023
| | |
27.04.23 |
Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
| | |
20.04.23 |
Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd. Approves Cash Dividend for 2022, Payable on 04 May 2023
| | |
29.03.23 |
Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd. Proposes Cash Dividend for the Year 2022
| | |
12.03.23 |
Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022
| |
Keine Ergebnisse zu dieser Suche Bitte wählen Sie Ihre Ausgabe Alle länderspezifischen Finanzinformationen
MarketScreener is also available in this country: United States.
Switch edition
Bei der aktuellen länderspezifischen Edition bleiben
| 
